Literature DB >> 23515680

ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram.

L Karlsson1, H Green, A L Zackrisson, F Bengtsson, I Jakobsen Falk, B Carlsson, J Ahlner, F C Kugelberg.   

Abstract

P-glycoprotein (P-gp), encoded by the ABCB1/MDR1 gene, is a drug transporter at the blood-brain barrier. Several polymorphisms in the ABCB1 gene are known to affect the activity and/or expression of P-gp, thereby influencing the treatment response and toxicity of P-gp substrates like citalopram and venlafaxine. In this study, we aimed to investigate the frequency of ABCB1 genotypes in forensic autopsy cases involving these two antidepressants. Further, the distribution of ABCB1 genotypes in deaths related to intoxication was compared to cases not associated to drug intoxication. The study included 228 forensic autopsy cases with different causes and manners of deaths. The ABCB1 single nucleotide polymorphisms (SNPs) G1199A, C1236T, C3435T and G2677T/A for these individuals were determined. The SNPs C1236T and C3435T in venlafaxine-positive cases were significantly different between the intoxication cases and non-intoxications. This was not seen for cases involving citalopram, indicating that the effect of genetic variants might be substrate specific. This novel finding should, however, be confirmed in future studies with larger number of cases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23515680     DOI: 10.1007/s00414-013-0849-0

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  53 in total

1.  Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data.

Authors:  Nicholas A Buckley; Peter R McManus
Journal:  BMJ       Date:  2002-12-07

2.  Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients.

Authors:  Nada Bozina; Martina Rojnic Kuzman; Vesna Medved; Nikolina Jovanovic; Jadranka Sertic; Ljubomir Hotujac
Journal:  J Psychiatr Res       Date:  2006-11-20       Impact factor: 4.791

3.  Toxicogenetics--cytochrome P450 microarray analysis in forensic cases focusing on morphine/codeine and diazepam.

Authors:  H Andresen; C Augustin; T Streichert
Journal:  Int J Legal Med       Date:  2012-08-17       Impact factor: 2.686

4.  High frequency of occurrence of CYP2D6 gene duplication/multiduplication indicating ultrarapid metabolism among suicide cases.

Authors:  A L Zackrisson; B Lindblom; J Ahlner
Journal:  Clin Pharmacol Ther       Date:  2009-11-11       Impact factor: 6.875

5.  Computer-aided headspace gas chromatography applied to blood-alcohol analysis: importance of online process control.

Authors:  A W Jones; J Schuberth
Journal:  J Forensic Sci       Date:  1989-09       Impact factor: 1.832

6.  Localization of the human multiple drug resistance gene, MDR1, to 7q21.1.

Authors:  D F Callen; E Baker; R N Simmers; R Seshadri; I B Roninson
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

7.  Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.

Authors:  I M Whyte; A H Dawson; N A Buckley
Journal:  QJM       Date:  2003-05

8.  Antidepressants and ABCB1 gene C3435T functional polymorphism: a naturalistic study.

Authors:  Patrick Menu; Florence Gressier; Céline Verstuyft; Patrick Hardy; Laurent Becquemont; Emmanuelle Corruble
Journal:  Neuropsychobiology       Date:  2010-07-22       Impact factor: 2.328

9.  CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response.

Authors:  Marianne Gex-Fabry; Chin B Eap; Beatrice Oneda; Nicola Gervasoni; Jean-Michel Aubry; Guido Bondolfi; Gilles Bertschy
Journal:  Ther Drug Monit       Date:  2008-08       Impact factor: 3.681

10.  Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample.

Authors:  Eric J Peters; Susan L Slager; Jeffrey B Kraft; Greg D Jenkins; Megan S Reinalda; Patrick J McGrath; Steven P Hamilton
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

View more
  4 in total

Review 1.  Reliability of In Vitro and In Vivo Methods for Predicting the Effect of P-Glycoprotein on the Delivery of Antidepressants to the Brain.

Authors:  Yi Zheng; Xijing Chen; Leslie Z Benet
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

Review 2.  PharmGKB summary: venlafaxine pathway.

Authors:  Katrin Sangkuhl; Julia C Stingl; Miia Turpeinen; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-01       Impact factor: 2.089

Review 3.  Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.

Authors:  Stefan Wolking; Elke Schaeffeler; Holger Lerche; Matthias Schwab; Anne T Nies
Journal:  Clin Pharmacokinet       Date:  2015-07       Impact factor: 6.447

4.  A common polymorphism in the ABCB1 gene is associated with side effects of PGP-dependent antidepressants in a large naturalistic Dutch cohort.

Authors:  P M Bet; E C Verbeek; Y Milaneschi; D B M Straver; T Uithuisje; M R Bevova; J G Hugtenburg; P Heutink; B W J H Penninx; W J G Hoogendijk
Journal:  Pharmacogenomics J       Date:  2015-05-19       Impact factor: 3.550

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.